RD Med: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RD Med
Largest movements
- Cash +€146,464
up €146,464 (+193.4%), from €75,726 to €222,190
mainly Net result for the year (+€118,489) and Current investments (+€116,865)
- Current investments -€116,865
down €116,865 (-77.9%), from €150,000 to €33,135
- Tangible fixed assets +€35,297
up €35,297 (+354.3%), from €9,962 to €45,259
of which Furniture and vehicles: +€35,942
- Receivables within one year -€21,291
down €21,291 (-20.0%), from €106,225 to €84,935
of which Trade receivables: -€14,348
- Reserves +€48,750
up €48,750 (+16.3%), from €300,000 to €348,750
- Tax, wage and social debts -€4,468
down €4,468 (-10.0%), from €44,707 to €40,240
- Gross operating margin -€11,812
down €11,812 (-6.8%), from €174,710 to €162,898
- Depreciation +€6,606
up €6,606 (+239.4%), from €2,759 to €9,364
- Taxes -€4,343
down €4,343 (-10.7%), from €40,734 to €36,391
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €352,213 | €395,860 | +€43,646 | +12.4% |
| Fixed assets | 21/28 | €17,462 | €52,759 | +€35,297 | +202.1% |
| Tangible fixed assets | 22/27 | €9,962 | €45,259 | +€35,297 | +354.3% |
| Plant, machinery and equipment | 23 | - | €2,114 | +€2,114 | |
| Furniture and vehicles | 24 | - | €35,942 | +€35,942 | |
| Other tangible fixed assets | 26 | €9,962 | €7,203 | -€2,759 | -27.7% |
| Financial fixed assets | 28 | €7,500 | €7,500 | = | 0.0% |
| Current assets | 29/58 | €334,751 | €343,101 | +€8,349 | +2.5% |
| Amounts receivable within one year | 40/41 | €106,225 | €84,935 | -€21,291 | -20.0% |
| Trade receivables | 40 | €90,283 | €75,935 | -€14,348 | -15.9% |
| Other amounts receivable | 41 | €15,942 | €9,000 | -€6,942 | -43.5% |
| Current investments | 50/53 | €150,000 | €33,135 | -€116,865 | -77.9% |
| Cash at bank and in hand | 54/58 | €75,726 | €222,190 | +€146,464 | +193.4% |
| Deferred charges and accrued income | 490/1 | €2,800 | €2,840 | +€40 | +1.4% |
| Total equity and liabilities | 10/49 | €352,213 | €395,860 | +€43,646 | +12.4% |
| Equity | 10/15 | €305,417 | €353,906 | +€48,489 | +15.9% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €300,000 | €348,750 | +€48,750 | +16.3% |
| Distributable reserves | 133 | €300,000 | €348,750 | +€48,750 | +16.3% |
| Profit (loss) carried forward | 14 | €417 | €156 | -€261 | -62.6% |
| Amounts payable | 17/49 | €46,797 | €41,954 | -€4,843 | -10.3% |
| Amounts payable within one year | 42/48 | €46,797 | €41,954 | -€4,843 | -10.3% |
| Trade debts | 44 | €2,089 | €1,303 | -€787 | -37.6% |
| Suppliers | 440/4 | €2,089 | €1,303 | -€787 | -37.6% |
| Taxes, remuneration and social security | 45 | €44,707 | €40,240 | -€4,468 | -10.0% |
| Taxes | 450/3 | €44,707 | €40,240 | -€4,468 | -10.0% |
| Other amounts payable | 47/48 | €0 | €411 | +€411 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,759 | €9,364 | +€6,606 | +239.4% |
| Other operating charges | 640/8 | €332 | €464 | +€132 | +39.7% |
| Gross operating margin | 9900 | €174,710 | €162,898 | -€11,812 | -6.8% |
| Operating profit (loss) | 9901 | €171,619 | €153,070 | -€18,549 | -10.8% |
| Financial income | 75/76B | €806 | €2,286 | +€1,481 | +183.8% |
| Recurring financial income | 75 | €806 | €2,286 | +€1,481 | +183.8% |
| Financial charges | 65/66B | €98 | €476 | +€378 | +388.2% |
| Recurring financial charges | 65 | €98 | €476 | +€378 | +388.2% |
| Profit (loss) for the period before taxes | 9903 | €172,327 | €154,880 | -€17,447 | -10.1% |
| Income taxes | 67/77 | €40,734 | €36,391 | -€4,343 | -10.7% |
| Profit (loss) for the period | 9904 | €131,593 | €118,489 | -€13,104 | -10.0% |
| Profit (loss) for the period to be appropriated | 9905 | €131,593 | €118,489 | -€13,104 | -10.0% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.